<DOC>
	<DOCNO>NCT02949960</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy DMT210 Gel , 5 % compare vehicle control follow 28 day twice-daily topical application select target lesion male female patient mild moderate atopic dermatitis ( AD ) .</brief_summary>
	<brief_title>DMT210 Topical Gel Treatment Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Male female 12 year old Patient chronic , stable AD present least 3 month 535 % ( inclusive ) BSA ( Body Surface Area ) AD involvement Patient two analogous , Target Lesions ; one lesion within two Treatment Areas Patient willing able comply protocol Patient use topical therapy AD within Treatment Areas 2 week baseline</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Eczema</keyword>
	<keyword>Dermatitis</keyword>
	<keyword>Skin Diseases</keyword>
	<keyword>Skin Diseases , Genetic</keyword>
	<keyword>Dermatitis , Atopic</keyword>
	<keyword>Skin Diseases , Eczematous</keyword>
	<keyword>Hypersensitivity</keyword>
	<keyword>Immune System Diseases</keyword>
</DOC>